Porter D W, Nelson V C, Fivash M J, Kasprzak K S
Laboratory of Comparative Carcinogenesis, National Cancer Institute-FCRDC, Frederick, Maryland 21702, USA.
Chem Res Toxicol. 1996 Dec;9(8):1375-81. doi: 10.1021/tx9600816.
Promutagenic 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) levels are increased in DNA of animals exposed to carcinogenic metals, such as Ni(II). Besides being generated directly in genomic DNA, 8-oxo-dG may be incorporated there from 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-oxo-dGTP), a product of oxidative damage to the nucleotide pool. The Escherichia coli dGTPase MutT, and analogous dGTPases in rats and humans, have been suggested as a defense against such incorporation because they hydrolyze 8-oxo-dGTP to 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-monophosphate (8-oxo-dGMP). MutT and its mammalian counterparts are Mg(II)-dependent enzymes. Ni(II), in turn, is known to interact antagonistically with Mg(II) in biological systems. Thus, we hypothesized that Ni(II) might inhibit the activity of MutT. As an initial examination of this hypothesis, we conducted enzyme kinetic studies of MutT to determine the effect of Ni(II) on MutT activity and the mechanisms involved. As found, Ni(II) inhibited MutT in a concentration-dependent manner when either dGTP or 8-oxo-dGTP was the nucleotide substrate. Ni(II) was determined to be an uncompetitive inhibitor of MutT with respect to Mg(II) when dGTP was the substrate, with apparent Ki of 1.2 mM Ni(II), and a noncompetitive inhibitor with respect to Mg(II) when 8-oxo-dGTP was the substrate, with apparent Ki of 0.9 mM Ni(II). Hence, the two metal cations did not compete with each other for binding at the MutT active site. This makes it difficult to predict Ni(II) effects on 8-oxo-dGTPases of other species. However, based upon the amino acid sequences of human and rat MutT-like dGTPases, their capacity for Ni(II) binding should be greater than that of MutT. Whether this could lead to stronger inhibition of those enzymes by Ni(II), or not, remains to be investigated.
暴露于致癌金属(如镍(II))的动物DNA中,促诱变的8-氧代-7,8-二氢-2'-脱氧鸟苷(8-氧代-dG)水平会升高。8-氧代-dG除了直接在基因组DNA中生成外,还可能从核苷酸池氧化损伤的产物8-氧代-7,8-二氢-2'-脱氧鸟苷5'-三磷酸(8-氧代-dGTP)掺入其中。大肠杆菌dGTP酶MutT以及大鼠和人类中的类似dGTP酶,被认为是抵御这种掺入的一种防御机制,因为它们能将8-氧代-dGTP水解为8-氧代-7,8-二氢-2'-脱氧鸟苷5'-单磷酸(8-氧代-dGMP)。MutT及其哺乳动物对应物是依赖镁(II)的酶。反过来,已知镍(II)在生物系统中与镁(II)发生拮抗作用。因此,我们推测镍(II)可能会抑制MutT的活性。作为对这一假设的初步研究,我们对MutT进行了酶动力学研究,以确定镍(II)对MutT活性的影响及其相关机制。结果发现,当dGTP或8-氧代-dGTP作为核苷酸底物时,镍(II)以浓度依赖的方式抑制MutT。当dGTP作为底物时,镍(II)被确定为MutT相对于镁(II)的非竞争性抑制剂,表观抑制常数(Ki)为1.2 mM镍(II);当8-氧代-dGTP作为底物时,镍(II)是相对于镁(II)的非竞争性抑制剂,表观Ki为0.9 mM镍(II)。因此,这两种金属阳离子不会在MutT活性位点相互竞争结合位点。这使得很难预测镍(II)对其他物种8-氧代-dGTP酶的影响。然而,根据人类和大鼠MutT样dGTP酶的氨基酸序列,它们结合镍(II)的能力应该比MutT更强。这是否会导致镍(II)对这些酶的抑制作用更强仍有待研究。